Recent progress in plasmonic nanoparticle‐based biomarker detection and cytometry for the study of central nervous system disorders

Neurological disorders affect hundreds of millions of people around the world, are often life‐threatening, untreatable, and can result in debilitating symptoms. The high prevalence of these disorders, which feature biochemical or structural abnormalities in neuronal systems, has spurned innovations in both rapid and early detection to assist in the selection of appropriate treatment strategies to improve the patients' quality of life. Plasmonic...